 "vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab")
Shares of Indoco Remedies gained 5 per cent to Rs 282 on the BSE in the morning trade on Wednesday, thereby surging 28 per cent in the past four trading days after getting approval from the US health regulator for blood-thinning drug Apixaban tablets. The stock of the pharmaceutical company was trading close to its 52-week high level of Rs 285, touched on April 13, 2020.
"The company has received approval from the US Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Apixaban tablets in the strengths of 2.5 mg and 5 mg,"
